The company has extended functional and industry Performance Blueprints with TM1 technology that it gained when it acquired Applix earlier this year. The intention is that existing Cognos customers can use the planning and analytic features of TM1, in particular in the life sciences blueprints that address a sales and marketing investment area for Samples Allocation and Sales Quote management. The new blueprint will be available free of charge in calendar Q1.
“The Cognos plan for integrating the Applix solution is based upon three main tenets that are aligned with customer requirements,” said Kathleen Wilhide Research Director, Compliance and Business Performance Management Solutions at IDC, analysing the move.
In what it says is a drive to map out future solution milestones, Cognos has formed a customer advisory board for joint Cognos/Applix clients to provide guidance on integration strategy and product innovation roadmap. Leading organisations such as American Express, Amgen, BAE Systems, NSTAR, Wiley and Simmer are now members of the advisory board.